Mystery shopper results Remedy Meds contact information Phone number: 551-239-9025 Email: [email protected] Features and benefits Weight-loss guarantee Unlimited video calls with licensed medical doctors Upfront pricing on GLP-1 medication Oral and injectable semaglutide and tirzepatide Fast delivery of weight loss medication Once approved for GLP-1 medication, Remedy will ship either compounded semaglutide or tirzepatide directly to your home with no additional shipping fees
doi: 10.1007/s10858-005-0178-9 Sollod, Brianna L., Wilson, David, Zhaxybayeva, Olga, Gogarten, J
BENEFITS Triple receptor activation studied for simultaneous GLP-1, GIP, and glucagon engagement Metabolic research explored in Phase 2 clinical trials with notable body-composition results Glucagon component linked to thermogenesis and energy-expenditure pathways Next-generation compound investigated as an advancement over dual-agonist approaches Comparative pharmacology assessed alongside mono- and dual-agonists in research settings WHAT RESEARCHERS LOOK AT Triple-agonist binding affinity across GLP-1, GIP, and glucagon receptors Additive effects of glucagon-receptor activation on energy expenditure Dose-response and tolerability profiling from clinical-trial data Comparative outcomes vs tirzepatide and semaglutide Pharmacokinetic profiling and receptor selectivity QUICK SPECS Form: Lyophilized peptide powder Net per vial: 10 mg Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS CAS: 2381089-83-2 Classification: Triple GLP-1/GIP/glucagon receptor agonist WHY CHOOSE DURHAM PEPTIDES FOR RETATRUTIDE
Eric Christianson, PharmD, BCPS, BCGP
Never adjust your GLP-1 dose without coordinating with both providers
